MRSH financials

Marsh & McLennan Companies, Inc. · end-of-day data as of Oct 16, 2026

Marsh & McLennan Companies, Inc.

MRSH · $89.88B

$188.35+4.8%last 60 sessions · close Oct 16, 2026

$156.41$196.4452 weeks

Hold · 23 analystsPT $204.59 +8.6%

P/E vs own+6.7%
P/E vs sector+58.3%
Target upside+8.6%
Off 52w high-4.1%
Insiders-$8.21M
FCF yield+4.6%
Earnings in111d
Trendbullish
Sector▲ -3.9%
RSI72
MA20×50↑ in ~16d
Volume1.0x
Support-3.2%
Resistance+2.3%

MRSH reported revenue of $6.86B for the quarter ended Sep 30, 2026 (Q3 FY2026), up 8.1% from a year earlier. It posted diluted EPS of $1.69, free cash flow of $1.4B and a net margin of 11.8%.

Valuation

P/E22.5x
P/E vs own+6.7%
P/E vs sector+58.3%
FCF yield+4.6%
Market cap$89.88B

Quarterly results

Q3 FY2026: Revenue +8.1% year over year, free cash flow 20.4% of revenue, operating margin 17.7%.

RevenueFree cash flow


Q3 FY2026	Sep 30, 2026	$6.86B	1.69	$1.4B	40.6%	17.7%	11.8%
Q2 FY2026	Jun 30, 2026	$7.4B	2.63	$1.45B	44.1%	25.6%	17.1%
Q1 FY2026	Mar 31, 2026	$7.6B	2.36	-$750M	45.6%	23.1%	15.1%
Q4 FY2025	Dec 31, 2025	$6.59B	1.68	$2.06B	40.3%	18.5%	12.4%
Q3 FY2025	Sep 30, 2025	$6.35B	1.51	$2.01B	38.7%	18.4%	11.8%
Q2 FY2025	Jun 30, 2025	$6.97B	2.45	$1.61B	44.1%	26.2%	17.4%
Q1 FY2025	Mar 31, 2025	$7.06B	2.79	-$677M	45.5%	28.4%	19.6%
Q4 FY2024	Dec 31, 2024	$6.07B	1.59	$1.88B	40.2%	18.8%	13.0%
Q3 FY2024	Sep 30, 2024	$5.7B	1.51	$1.84B	39.6%	19.4%	13.1%
Q2 FY2024	Jun 30, 2024	$6.22B	2.27	$1.14B	44.5%	26.4%	18.1%
Q1 FY2024	Mar 31, 2024	$6.47B	2.82	-$868M	46.4%	29.7%	21.6%
Q4 FY2023	Dec 31, 2023	$5.55B	1.52	$1.66B	41.2%	19.9%	13.6%